Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors

بواسطة Lydia W.T. Cheung, Shuangxing Yu, Dong Zhang, Jie Li, Patrick K.S. Ng, Nattapon Panupinthu, Shreya Mitra, Zhenlin Ju, Qinghua Yu, Han Liang, David H. Hawke, Yiling Lu, Russell R. Broaddus, Gordon B. Mills
منشور في 2018